百济神州三季度营收71.4亿增26.9% 净亏损8亿
财中社11月12日电百济神州（688235/06160/BGNE）发布截至2024年9月30日的三个月及九个月主要财务数据。2024年第三季度，营业总收入为71.4亿元，同比增长26.9%；前九个月营业总收入为191.4亿元，同比增长48.6%。其中，产品收入为70.8亿元，同比增长65.1%；前九个月产品收入为189.9亿元，同比增长72.9%。然而，归属于母公司所有者的净亏损为8亿元，同比下降160.4%；前九个月净亏损为36.9亿元，未提供同比数据。
报告期末，公司总资产为408.6亿元，较年初减少0.6%；归属于母公司的所有者权益为241.7亿元，较年初减少3.7%。产品收入增长主要得益于自主研发的百悦泽®和百泽安®的销售增长，尤其是百悦泽®在全球市场的表现显著，销售额达49.14亿元，同比增长91.1%。公司表示，未来将继续推进自主研发药物的全球化进展，以提高药物的可及性。
（文章来源：财中社）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10